Skip to main content
CDC Website

Persons who inject drugs

HIV and Injection Drug Use Syringe Services Programs for HIV Prevention

This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

Hepatitis D: What You Need to Know

This information sheet provides essential insights into Hepatitis D, emphasizing its dependence on Hepatitis B for infection. The sheet underscores prevention strategies, notably the protective role of the Hepatitis B vaccine, and highlights the need for awareness among high-risk groups to prevent severe liver complications.

Hepatitis C: What You Need to Know

This information sheet provides essential insights into Hepatitis C, detailing its transmission, symptoms, and the importance of early detection. It emphasizes the availability of effective treatments that can cure the infection, highlighting the need for regular testing and awareness to prevent long-term liver complications.

Current Methadone Access: Where are we now?

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 2: Part 2: Current Methadone Access: Where are we now?” webinar on September 24 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

History of the Methadone System: How did we get here?

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

History of the Methadone System: How did we get here?

NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.

Patient Navigation for People Who Use Drugs

In 2019, NASTAD Drug User Health received CDC funding to oversee a demonstration project that would fund syringe services programs (SSPs) to provide patient navigation services for participants. Between 2020 and 2022, eight SSPs around the United States developed and implemented patient navigation services to facilitate engagement with medical and social services for people who use drugs (PWUD).